These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11063351)

  • 1. Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation?
    Houde I; Isenring P; Boucher D; Noël R; Lachanche JG
    Transplantation; 2000 Oct; 70(8):1251-3. PubMed ID: 11063351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report.
    Ducloux D; Fournier V; Bresson-Vautrin C; Rebibou JM; Billerey C; Saint-Hillier Y; Chalopin JM
    Transplantation; 1998 Jun; 65(11):1504-6. PubMed ID: 9645813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.
    Schnuelle P; van der Heide JH; Tegzess A; Verburgh CA; Paul LC; van der Woude FJ; de Fijter JW
    J Am Soc Nephrol; 2002 Feb; 13(2):536-543. PubMed ID: 11805185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
    Song Y; Xue W; Tian P; Ding X; Pan X; Yan H; Hou J; Feng X; Xiang H; Tian X; Qin G; Fan X
    Eur J Clin Pharmacol; 2011 Jun; 67(6):553-62. PubMed ID: 21279337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
    Meier-Kriesche HU; Friedman G; Jacobs M; Mulgaonkar S; Vaghela M; Kaplan B
    Transplantation; 1999 Nov; 68(10):1496-502. PubMed ID: 10589946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study.
    Dudley C; Pohanka E; Riad H; Dedochova J; Wijngaard P; Sutter C; Silva HT;
    Transplantation; 2005 Feb; 79(4):466-75. PubMed ID: 15729174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
    Sells RA; Bakran A; Brown MW; Grinyo J; Hammad A; Hyatt D; Owens G
    Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
    [No Abstract]   [Full Text] [Related]  

  • 13. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
    Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
    Wüthrich RP; Weinreich T; Ambühl PM; Schwarzkopf AK; Candinas D; Binswanger U
    Nephrol Dial Transplant; 1999 Feb; 14(2):394-9. PubMed ID: 10069195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.
    Smak Gregoor PJ; de Sévaux RG; Ligtenberg G; Hoitsma AJ; Hené RJ; Weimar W; Hilbrands LB; van Gelder T
    J Am Soc Nephrol; 2002 May; 13(5):1365-73. PubMed ID: 11961025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.
    Michielsen LA; van Zuilen AD; Verhaar MC; Wisse BW; Kamburova EG; Joosten I; Allebes WA; van der Meer A; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Hilbrands LB
    Nephrol Dial Transplant; 2019 Aug; 34(8):1417-1422. PubMed ID: 30561730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte sodium lithium countertransport in renal transplant recipients with mycophenolate mofetil and low-dose cyclosporine.
    Vareesangthip K; Hanlakorn P; Suwannaton L; Larpkitkachorn R; Chuawattana D; Pidetcha P; Ong-Aj-Yooth L
    Transplant Proc; 2004 Dec; 36(10):3032-5. PubMed ID: 15686688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.
    Zanker B; Schneeberger H; Rothenpieler U; Hillebrand G; Illner WD; Theodorakis I; Stangl M; Land W
    Transplantation; 1998 Jul; 66(1):44-9. PubMed ID: 9679820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.